by Paul Enck
A new systematic review and meta-analysis concludes that probiotics are associated with a lower risk of symptomatic C. difficile infection.
by Paul Enck
A new double-blinded randomized study has found that rifaximin—a poorly absorbable antibiotic acting mainly in the gut —may exhibit stress-reducing effects by modulating our gut microbiota in a way similar to probiotics.
by Andreu Prados
A recent study has found that many non-antibiotic human-targeted drugs may have a direct effect on the gut microbiome that potentially contribute to both their gastrointestinal side effects and therapeutic actions.
by GMFH Editing Team
The document below features exclusive GMFH content and is intended to serve as a key resource for health professionals.
by GMFH Editing Team
The functional gastrointestinal disorders (FGIDs) that are characterized by persistent and recurring GI symptoms.
A scientific committee chaired has taken care to put together a program that covers the most relevant issues in the field today.
by Andreu Prados
A recent study has found that a particular gut microbe modulates immune response to influenza infection in mice through breaking down flavonoids naturally found in vegetal foods.
by Andreu Prados
A new rodent study has found that antibiotics taken in pregnancy may lead to gut dysbiosis, immune dysfunction and increased IBD risk in genetically susceptible rat offspring.
by Andreu Prados
A recent study, led by Dr. Simone Becattini and Dr. Eric G. Pamer from the Memorial Sloan-Kettering Cancer Center in New York, has found that targeting the gut microbiota could improve colonization resistance against severe listeriosis.
by Andreu Prados
A recent review, led by Dr. Hai Lu from the Department of Orthopedic Surgery at The Third Affiliated Hospital of Southern Medical University in Guangzhou (China), discusses the existing evidence for the role of gut microbiota in ankylosing spondylitis.
